<DOC>
	<DOCNO>NCT00435760</DOCNO>
	<brief_summary>This trial evaluate rate onset bronchodilator action aclidinium bromide compare placebo tiotropium patient severe COPD single dose treatment .</brief_summary>
	<brief_title>Clinical Trial Assess Rate Onset Bronchodilator Action Severe Stable Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description>This single dose , randomise , double-blind , double-dummy , 3 period cross-over , placebo control , multinational , multicentre trial .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Males female age ≥ 40 year Current exsmokers ≥ 10 packyear Clinical diagnosis severe stable COPD History current diagnosis asthma , allergic rhinitis , atopy Respiratory tract infection acute COPD exacerbation last 6 week Hospitalised acute COPD exacerbation last 3 month Evidence contraindicate use anticholinergic drug</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>COPD</keyword>
</DOC>